دورية أكاديمية

Exosomes in Vascular/Neurological Disorders and the Road Ahead.

التفاصيل البيبلوغرافية
العنوان: Exosomes in Vascular/Neurological Disorders and the Road Ahead.
المؤلفون: Alzahrani FA; Department of Biochemistry, King Fahad Center for Medical Research, King Abdulaziz University, Jeddah 21589, Saudi Arabia., Riza YM; Department of Biochemistry, King Fahad Center for Medical Research, King Abdulaziz University, Jeddah 21589, Saudi Arabia., Eid TM; Department of Biochemistry, King Fahad Center for Medical Research, King Abdulaziz University, Jeddah 21589, Saudi Arabia., Almotairi R; Department of Medical Laboratory Technology, Prince Fahad bin Sultan Chair for Biomedical Research, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk 71491, Saudi Arabia., Scherschinski L; Department of Translational Neuroscience, Barrow Neurological Institute, St Joseph's Hospital and Medical Center, Phoenix, AZ 85013, USA., Contreras J; Department of Translational Neuroscience, Barrow Neurological Institute, St Joseph's Hospital and Medical Center, Phoenix, AZ 85013, USA., Nadeem M; Department of Translational Neuroscience, Barrow Neurological Institute, St Joseph's Hospital and Medical Center, Phoenix, AZ 85013, USA., Perez SE; Department of Translational Neuroscience, Barrow Neurological Institute, St Joseph's Hospital and Medical Center, Phoenix, AZ 85013, USA., Raikwar SP; Department of Translational Neuroscience, Barrow Neurological Institute, St Joseph's Hospital and Medical Center, Phoenix, AZ 85013, USA., Jha RM; Department of Neurology, Barrow Neurological Institute, St Joseph's Hospital and Medical Center, Phoenix, AZ 85013, USA., Preul MC; Department of Neurosurgery, Barrow Neurological Institute, St Joseph's Hospital and Medical Center, Phoenix, AZ 85013, USA., Ducruet AF; Department of Neurosurgery, Barrow Neurological Institute, St Joseph's Hospital and Medical Center, Phoenix, AZ 85013, USA., Lawton MT; Department of Neurosurgery, Barrow Neurological Institute, St Joseph's Hospital and Medical Center, Phoenix, AZ 85013, USA., Bhatia K; School of Mathematical and Natural Sciences, Arizona State University, Glendale, AZ 85306, USA., Akhter N; Department of Biology, Arizona State University, Lake Havasu City, AZ 86403, USA., Ahmad S; Department of Translational Neuroscience, Barrow Neurological Institute, St Joseph's Hospital and Medical Center, Phoenix, AZ 85013, USA.; Department of Neurosurgery, Barrow Neurological Institute, St Joseph's Hospital and Medical Center, Phoenix, AZ 85013, USA.; Phoenix Veterans Affairs (VA) Health Care System, Phoenix, AZ 85012, USA.
المصدر: Cells [Cells] 2024 Apr 12; Vol. 13 (8). Date of Electronic Publication: 2024 Apr 12.
نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI
مواضيع طبية MeSH: Exosomes*/metabolism, Humans ; Animals ; Neurodegenerative Diseases/metabolism ; Neurodegenerative Diseases/pathology ; Vascular Diseases/metabolism ; Vascular Diseases/pathology ; Nervous System Diseases/metabolism ; Nervous System Diseases/pathology
مستخلص: Neurodegenerative diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), stroke, and aneurysms, are characterized by the abnormal accumulation and aggregation of disease-causing proteins in the brain and spinal cord. Recent research suggests that proteins linked to these conditions can be secreted and transferred among cells using exosomes. The transmission of abnormal protein buildup and the gradual degeneration in the brains of impacted individuals might be supported by these exosomes. Furthermore, it has been reported that neuroprotective functions can also be attributed to exosomes in neurodegenerative diseases. The potential neuroprotective functions may play a role in preventing the formation of aggregates and abnormal accumulation of proteins associated with the disease. The present review summarizes the roles of exosomes in neurodegenerative diseases as well as elucidating their therapeutic potential in AD, PD, ALS, HD, stroke, and aneurysms. By elucidating these two aspects of exosomes, valuable insights into potential therapeutic targets for treating neurodegenerative diseases may be provided.
References: Circulation. 2019 Mar 5;139(10):1320-1334. (PMID: 30586743)
Curr Genomics. 2010 Nov;11(7):537-61. (PMID: 21532838)
Neuroscience. 2019 May 1;405:148-157. (PMID: 29660443)
Mol Neurodegener. 2012 Aug 24;7:42. (PMID: 22920859)
Transl Neurodegener. 2022 Nov 27;11(1):50. (PMID: 36437458)
Int J Mol Sci. 2017 Feb 22;18(2):. (PMID: 28241427)
PLoS Biol. 2014 Jun 03;12(6):e1001874. (PMID: 24893313)
Pharmacol Ther. 2018 Aug;188:1-11. (PMID: 29476772)
Stem Cells. 2016 Dec;34(12):2943-2955. (PMID: 27350036)
Hum Cell. 2021 Sep;34(5):1346-1359. (PMID: 34240392)
Mol Aspects Med. 2018 Apr;60:62-68. (PMID: 29196098)
Cells. 2019 Sep 14;8(9):. (PMID: 31540100)
Acta Neuropathol. 2016 Sep;132(3):391-411. (PMID: 26910103)
Nat Rev Neurosci. 2016 Mar;17(3):160-72. (PMID: 26891626)
Nat Rev Immunol. 2014 Mar;14(3):195-208. (PMID: 24566916)
Biochim Biophys Acta Mol Basis Dis. 2018 Dec;1864(12):3771-3785. (PMID: 30315929)
Integr Med Res. 2023 Sep;12(3):100968. (PMID: 37664456)
Genes Dis. 2023 Apr 10;11(2):1009-1021. (PMID: 37692510)
Nucleic Acids Res. 2012 Oct;40(18):9272-85. (PMID: 22821563)
Stroke. 2018 May;49(5):1083-1090. (PMID: 29669873)
J Cereb Blood Flow Metab. 2013 Nov;33(11):1711-5. (PMID: 23963371)
Acta Pharmacol Sin. 2018 Apr;39(4):501-513. (PMID: 29219950)
J Extracell Vesicles. 2014 Aug 04;3:. (PMID: 25143819)
Annu Rev Cell Dev Biol. 2000;16:113-43. (PMID: 11031232)
EBioMedicine. 2019 Feb;40:626-635. (PMID: 30711519)
Sci Rep. 2017 Mar 16;7:44433. (PMID: 28300134)
Int J Mol Sci. 2020 May 21;21(10):. (PMID: 32455791)
Cell Stem Cell. 2016 Feb 4;18(2):174-88. (PMID: 26849304)
Int J Mol Sci. 2022 May 17;23(10):. (PMID: 35628406)
Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9683-8. (PMID: 15210972)
Oncogene. 2008 Oct 6;27(45):5959-74. (PMID: 18836476)
Eur J Neurol. 2020 Jun;27(6):967-974. (PMID: 32150777)
Acta Pharmacol Sin. 2018 Apr;39(4):542-551. (PMID: 29417947)
J Clin Med. 2021 Aug 31;10(17):. (PMID: 34501378)
J Nanobiotechnology. 2024 Jan 28;22(1):41. (PMID: 38281957)
J Transl Med. 2005 Feb 21;3(1):9. (PMID: 15723705)
Mol Cell. 2014 Oct 23;56(2):193-204. (PMID: 25242146)
Pharmaceuticals (Basel). 2013;6(5):659-80. (PMID: 23894228)
Sci Rep. 2016 Feb 09;6:21507. (PMID: 26857143)
Cell Stem Cell. 2019 Nov 7;25(5):594-606. (PMID: 31703770)
Asian J Pharm Sci. 2018 Jan;13(1):1-11. (PMID: 32104373)
J Circ Biomark. 2015 Jul 17;4:7. (PMID: 28936243)
Sci Rep. 2016 Apr 22;6:24922. (PMID: 27102850)
Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):12048-53. (PMID: 23818581)
Cell Mol Neurobiol. 2016 Apr;36(3):459-70. (PMID: 26951563)
J Extracell Vesicles. 2020 Jun 18;9(1):1781427. (PMID: 32944170)
Brain. 2000 Feb;123 ( Pt 2):205-21. (PMID: 10648430)
Nat Cell Biol. 2011 Apr;13(4):423-33. (PMID: 21423178)
J Lipid Res. 2018 Sep;59(9):1554-1560. (PMID: 29853529)
J Biol Chem. 2011 Apr 22;286(16):14383-95. (PMID: 21300796)
Clin Sci (Lond). 2019 Nov 29;133(22):2265-2282. (PMID: 31657855)
Nat Neurosci. 2015 Nov;18(11):1584-93. (PMID: 26436904)
Epigenomics. 2019 Nov 1;11(15):1661-1677. (PMID: 31646884)
J Neurosurg. 2018 Jul 20;131(1):290-300. (PMID: 30028267)
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5003-8. (PMID: 21383194)
Tissue Barriers. 2015 Dec 22;4(1):e1131804. (PMID: 27141419)
Exp Neurol. 2018 Sep;307:109-117. (PMID: 29908146)
Stem Cells Transl Med. 2016 Jun;5(6):754-63. (PMID: 27160705)
Radiology. 1989 Aug;172(2):541-8. (PMID: 2748837)
Neurosci Lett. 2013 Aug 26;548:190-5. (PMID: 23792198)
Neural Regen Res. 2022 Mar;17(3):608-617. (PMID: 34380901)
Cell Mol Life Sci. 2021 Aug;78(15):5707-5729. (PMID: 34173837)
Curr Opin Neurobiol. 2016 Aug;39:101-7. (PMID: 27183381)
Cell. 1983 Jul;33(3):967-78. (PMID: 6307529)
Br J Haematol. 1967 May;13(3):269-88. (PMID: 6025241)
Neurochem Int. 2017 Dec;111:69-81. (PMID: 27539657)
Stem Cell Res Ther. 2022 Jan 29;13(1):42. (PMID: 35093176)
Lancet. 2003 Jul 12;362(9378):103-10. (PMID: 12867109)
Nat Biotechnol. 2011 Apr;29(4):341-5. (PMID: 21423189)
Leukemia. 2014 Apr;28(4):970-3. (PMID: 24445866)
Stroke. 2017 Mar;48(3):747-753. (PMID: 28232590)
Eur J Neurosci. 2011 May;33(9):1587-97. (PMID: 21447094)
Clin Cancer Res. 2018 Feb 15;24(4):896-905. (PMID: 29233903)
EMBO J. 2016 Feb 1;35(3):239-57. (PMID: 26758544)
Nat Commun. 2015 Jun 18;6:7321. (PMID: 26084661)
Transl Stroke Res. 2018 Oct;9(5):530-539. (PMID: 29285679)
Stroke. 2008 May;39(5):1569-74. (PMID: 18323495)
J Neuroinflammation. 2020 Jul 14;17(1):209. (PMID: 32664984)
Biochem Biophys Res Commun. 2017 Feb 19;483(4):1178-1186. (PMID: 27659705)
J Extracell Vesicles. 2015 Dec 31;4:30087. (PMID: 26725829)
J Biol Chem. 2013 May 31;288(22):15699-711. (PMID: 23592792)
J Neuroinflammation. 2019 Jan 15;16(1):8. (PMID: 30646897)
Front Neurosci. 2019 Jun 05;13:574. (PMID: 31231184)
Front Cardiovasc Med. 2017 Dec 11;4:78. (PMID: 29322046)
Neurochem Res. 2020 May;45(5):1020-1033. (PMID: 32016794)
Immunol Cell Biol. 2017 Feb;95(2):207-214. (PMID: 27616750)
Nature. 2018 Aug;560(7718):382-386. (PMID: 30089911)
Cell Res. 2014 Jun;24(6):766-9. (PMID: 24710597)
J Neurochem. 2012 Nov;123 Suppl 2:12-21. (PMID: 23050638)
Stroke. 1994 Apr;25(4):889-903. (PMID: 8160237)
Stem Cell Res Ther. 2013 Apr 25;4(2):34. (PMID: 23618405)
Int J Cancer. 2009 Oct 1;125(7):1514-22. (PMID: 19521982)
Neurosci Lett. 2019 Aug 24;708:134176. (PMID: 31173847)
J Neurosci. 2017 Sep 27;37(39):9550-9563. (PMID: 28893927)
Stroke. 2010 Aug;41(8):e519-36. (PMID: 20595669)
Int J Nanomedicine. 2019 Jun 17;14:4449-4460. (PMID: 31417253)
Eur J Cell Biol. 1984 Nov;35(2):256-63. (PMID: 6151502)
J Lipid Res. 2010 Aug;51(8):2105-20. (PMID: 20424270)
Int J Nanomedicine. 2018 Nov 20;13:7727-7747. (PMID: 30538455)
Prog Neurobiol. 2012 Apr;97(1):14-37. (PMID: 22414893)
Cell Mol Neurobiol. 2022 Oct;42(7):2393-2405. (PMID: 34185228)
Front Mol Neurosci. 2019 Oct 04;12:240. (PMID: 31636538)
Cell Death Dis. 2020 May 13;11(5):363. (PMID: 32404916)
Neuroscience. 2020 Aug 10;441:184-196. (PMID: 32502570)
Sci Rep. 2023 Sep 21;13(1):15731. (PMID: 37735227)
Cells. 2022 Sep 03;11(17):. (PMID: 36078156)
J Neuroinflammation. 2014 Jun 03;11:98. (PMID: 24889886)
Med Sci Monit. 2019 May 06;25:3329-3335. (PMID: 31056537)
Cell. 2017 Jul 13;170(2):352-366.e13. (PMID: 28709002)
Int J Mol Sci. 2021 Mar 14;22(6):. (PMID: 33799461)
Biochem Pharmacol. 2018 Feb;148:184-192. (PMID: 29305855)
Stem Cells Transl Med. 2015 Oct;4(10):1131-43. (PMID: 26339036)
Brain. 2020 May 1;143(5):1476-1497. (PMID: 32355963)
Nat Rev Immunol. 2023 Apr;23(4):236-250. (PMID: 35927511)
J Extracell Vesicles. 2020 Jan 24;9(1):1713540. (PMID: 32128071)
J Neuroinflammation. 2021 May 13;18(1):114. (PMID: 33985523)
Nat Rev Mol Cell Biol. 2018 Apr;19(4):213-228. (PMID: 29339798)
J Control Release. 2020 Jul 10;323:225-239. (PMID: 32289328)
Biology (Basel). 2022 May 24;11(6):. (PMID: 35741325)
Neurosurgery. 2007 Apr;60(4):649-56; discussion 656-7. (PMID: 17415201)
Cell Tissue Res. 2020 Dec;382(3):509-518. (PMID: 32852610)
J Mol Med (Berl). 2013 Apr;91(4):431-7. (PMID: 23519402)
J Transl Med. 2011 Mar 22;9:29. (PMID: 21418664)
J Biol Chem. 2014 Aug 29;289(35):24488-98. (PMID: 25037226)
Nature. 2014 Apr 24;508(7497):483-7. (PMID: 24739963)
Biomater Sci. 2016 May 24;4(6):910-21. (PMID: 26977477)
Sci Rep. 2019 Aug 8;9(1):11510. (PMID: 31395931)
Front Biosci. 2005 Jan 01;10:822-37. (PMID: 15569622)
Nat Cell Biol. 2007 Jun;9(6):654-9. (PMID: 17486113)
J Clin Invest. 2016 Apr 1;126(4):1208-15. (PMID: 27035812)
Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6328-33. (PMID: 20304794)
J Stroke Cerebrovasc Dis. 2012 Aug;21(6):445-51. (PMID: 21282068)
Int J Nanomedicine. 2014 Oct 21;9:4893-7. (PMID: 25364247)
Signal Transduct Target Ther. 2023 May 25;8(1):217. (PMID: 37231000)
World Neurosurg. 2017 Nov;107:148-159. (PMID: 28755916)
Mol Ther. 2011 Oct;19(10):1769-79. (PMID: 21915101)
J Proteomics. 2014 Jun 25;106:191-204. (PMID: 24769233)
Biomed Pharmacother. 2020 Jan;121:109593. (PMID: 31766102)
N Engl J Med. 1992 Sep 24;327(13):916-20. (PMID: 1513348)
Stem Cells. 2012 Jul;30(7):1556-64. (PMID: 22605481)
Platelets. 2017 May;28(3):214-221. (PMID: 28102737)
Acta Neuropathol. 2021 Sep;142(3):495-511. (PMID: 33991233)
PLoS One. 2016 Sep 23;11(9):e0163645. (PMID: 27661079)
Biochim Biophys Acta. 2016 Jun;1858(6):1139-51. (PMID: 26874206)
Science. 2006 Jun 2;312(5778):1389-92. (PMID: 16741123)
Stem Cells. 2013 Dec;31(12):2737-46. (PMID: 23630198)
J Neurosurg. 2000 Sep;93(3):379-87. (PMID: 10969934)
ACS Chem Neurosci. 2018 Jun 20;9(6):1416-1425. (PMID: 29543435)
Stroke. 2013 Dec;44(12):3613-22. (PMID: 24130141)
Atherosclerosis. 2019 Oct;289:64-72. (PMID: 31479773)
N Engl J Med. 1997 Jan 2;336(1):28-40. (PMID: 8970938)
Biomed Res Int. 2014;2014:704678. (PMID: 25478574)
Nat Commun. 2017 Oct 26;8(1):1145. (PMID: 29074968)
Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16842-7. (PMID: 16269541)
Stem Cell Res. 2013 May;10(3):301-12. (PMID: 23399448)
Cell Rep. 2016 May 3;15(5):978-987. (PMID: 27117408)
Stem Cell Res Ther. 2022 Jul 28;13(1):371. (PMID: 35902981)
Transl Stroke Res. 2013 Aug;4(4):432-46. (PMID: 23894255)
Nat Cell Biol. 2019 Jan;21(1):9-17. (PMID: 30602770)
Nat Cell Biol. 2008 May;10(5):619-24. (PMID: 18425114)
Lancet. 2002 Mar 9;359(9309):863-73. (PMID: 11897302)
Front Neurosci. 2017 May 17;11:273. (PMID: 28567000)
Front Cell Neurosci. 2015 Dec 17;9:476. (PMID: 26733805)
Mol Ther. 2008 Apr;16(4):782-90. (PMID: 18362931)
J Adv Res. 2021 Jan 08;31:61-74. (PMID: 34194832)
J Neurosurg. 1951 Nov;8(6):660-7. (PMID: 14889314)
Cell Rep. 2018 Jul 17;24(3):630-641. (PMID: 30021161)
Int J Mol Sci. 2021 Feb 22;22(4):. (PMID: 33671527)
J Neuroinflammation. 2020 Jan 10;17(1):15. (PMID: 31924219)
Nucleic Acids Res. 2010 Nov;38(20):7248-59. (PMID: 20615901)
Glia. 2021 Jul;69(7):1736-1748. (PMID: 33694209)
Metab Brain Dis. 2022 Oct;37(7):2545-2557. (PMID: 35907132)
Australas Ann Med. 1962 May;11:102-12. (PMID: 13916570)
Nat Rev Neurol. 2019 Apr;15(4):193-203. (PMID: 30700824)
Acta Neurol Belg. 2017 Mar;117(1):43-51. (PMID: 27473175)
Alzheimers Dement. 2015 Jun;11(6):600-7.e1. (PMID: 25130657)
Brain Res Bull. 2020 Dec;165:305-315. (PMID: 32956770)
J Am Heart Assoc. 2014 Sep 23;3(5):e000972. (PMID: 25249297)
Neurology. 2016 Mar 15;86(11):994-9. (PMID: 26865512)
Nat Med. 2013 Aug;19(8):998-1004. (PMID: 23921754)
Int J Mol Sci. 2016 Feb 06;17(2):175. (PMID: 26861306)
Circ Res. 2017 Feb 3;120(3):541-558. (PMID: 28154103)
J Biol Chem. 2011 Dec 23;286(51):44162-44176. (PMID: 21865156)
FASEB J. 2018 May 29;:fj201701138RR. (PMID: 29812968)
Neurosurgery. 2017 Dec 1;81(6):1021-1028. (PMID: 28431181)
Mol Aspects Med. 2023 Jun;91:101155. (PMID: 36456416)
J Neuroinflammation. 2022 Oct 6;19(1):248. (PMID: 36203194)
Stroke. 2009 Mar;40(3):994-1025. (PMID: 19164800)
Alzheimers Dement (Amst). 2016 May 07;3:63-72. (PMID: 27408937)
Immunity. 2017 Jul 18;47(1):51-65.e7. (PMID: 28666573)
J Biol Chem. 2019 Mar 8;294(10):3744-3759. (PMID: 30635404)
Neurosci Lett. 2022 Feb 6;771:136414. (PMID: 34954117)
Lancet Neurol. 2009 May;8(5):491-500. (PMID: 19375666)
Eur J Biochem. 1995 Feb 15;228(1):199-205. (PMID: 7883004)
Circ Res. 2014 Jan 17;114(2):345-53. (PMID: 24436430)
Exp Neurobiol. 2014 Mar;23(1):77-85. (PMID: 24737942)
J Atheroscler Thromb. 2020 Jun 1;27(6):545-610. (PMID: 31597886)
Neurobiol Aging. 2016 Apr;40:41-49. (PMID: 26973102)
Sci Rep. 2013;3:1197. (PMID: 23378928)
Transl Neurodegener. 2022 Dec 12;11(1):53. (PMID: 36510311)
فهرسة مساهمة: Keywords: Alzheimer’s; exosomes; neurological diseases; stroke; vascular diseases
تواريخ الأحداث: Date Created: 20240426 Date Completed: 20240426 Latest Revision: 20240515
رمز التحديث: 20240516
مُعرف محوري في PubMed: PMC11049650
DOI: 10.3390/cells13080670
PMID: 38667285
قاعدة البيانات: MEDLINE
الوصف
تدمد:2073-4409
DOI:10.3390/cells13080670